A Phase II/III clinical trial to assess safety and immune response of Trivalent, Live Attenuated Seasonal Influenza vaccine of SIIL in Adults, Elderly and Pediatric Populations

Trial Profile

A Phase II/III clinical trial to assess safety and immune response of Trivalent, Live Attenuated Seasonal Influenza vaccine of SIIL in Adults, Elderly and Pediatric Populations

Completed
Phase of Trial: Phase II/III

Latest Information Update: 31 Aug 2016

At a glance

  • Drugs Influenza vaccine live attenuated (Nasovac-S) (Primary)
  • Indications Influenza A virus infections; Influenza B virus infections
  • Focus Adverse reactions
  • Sponsors Serum Institute of India
  • Most Recent Events

    • 25 Aug 2012 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India
    • 29 May 2012 Status changed from not yet recruiting to active, no longer recruiting.
    • 14 May 2012 Actual end date (25 Aug 2012) added as reported by Clinical Trials Registry - India
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top